{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:45:27Z","timestamp":1791333927692,"version":"4.3.1"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2021,9,3]]},"abstract":"<jats:p>\n            Both the QuantiFERON-TB Gold Plus (QFT-Plus) and the QuantiFERON-TB Gold In-Tube (QFT-GIT) tests are interferon gamma (IFN-\u03b3) release assays (IGRAs) intended to detect\n            <jats:italic>in vitro<\/jats:italic>\n            cell-mediated immune responses to\n            <jats:named-content content-type=\"genus-species\">Mycobacterium tuberculosis<\/jats:named-content>\n            antigens. In this study, we retrospectively analyzed performance data for both the QFT-GIT and QFT-Plus test systems from over 2 million samples.\n          <\/jats:p>","DOI":"10.1128\/spectrum.00096-21","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T14:30:52Z","timestamp":1627482652000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":11,"title":["Retrospective Performance Analyses of over Two Million U.S. QuantiFERON Blood Sample Results"],"prefix":"10.1128","volume":"9","author":[{"given":"Caixia","family":"Bi","sequence":"first","affiliation":[{"name":"Quest Diagnostics, Secaucus, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Clark","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Master","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Kroll","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Salm","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"William A.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Quest Diagnostics, Secaucus, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"World Health Organization. 2020. Latent TB infection: updated and consolidated guidelines for programmatic management. http:\/\/www.who.int\/tb\/publications\/2018\/latent-tuberculosis-infection\/en\/. Retrieved 25 February 2021."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i34a01"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.11046"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6819a3"},{"key":"e_1_3_3_6_2","unstructured":"Qiagen. 2019. QuantiFERON-TB Gold Plus (QFT-Plus) ELISA package insert. https:\/\/www.quantiferon.com\/wp-content\/uploads\/2020\/01\/L1083163-R06-QF-TB-Gold-Plus-ELISA-IFU-CE.pdf. Retrieved 25 February 2021."},{"key":"e_1_3_3_7_2","unstructured":"Qiagen. 2016. QuantiFERON-Gold package insert. http:\/\/www.quantiferon.com\/wp-content\/uploads\/2017\/04\/English_QFT_ELISA_R04_082016.pdf. Retrieved 25 February 2021."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2018.10.014"},{"key":"e_1_3_3_9_2","unstructured":"Centers for Disease Control and Prevention. 2019. Reported tuberculosis in the United States 2018. https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2018\/default.htm. Retrieved 25 February 2021."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2410.180716"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6811a2"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140881"},{"key":"e_1_3_3_13_2","unstructured":"Centers for Disease Control and Prevention. 2015. Centers for Disease Control and Prevention Tuberculosis 2015 State and City Report. https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2015\/pdfs\/2015_surveillance_report_fullreport.pdf. Retrieved 4 March 2021."},{"key":"e_1_3_3_14_2","unstructured":"Migration Policy Institute. 2019. U.S. Immigrant population by metropolitan area. https:\/\/www.migrationpolicy.org\/programs\/data-hub\/charts\/us-immigrant-population-metropolitan-area. Retrieved 25 February 2021."},{"key":"e_1_3_3_15_2","unstructured":"Centers for Disease Control and Prevention. 2020. Table\u00a020. Tuberculosis cases and rates per 100 000 population by Hispanic ethnicity and Non-Hispanic race sex and age group: United States 2019. https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2019\/table20.htm. Retrieved 25 February 2021."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002119"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101122"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201243262"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2012.11.023"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2020.40.5.428"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.06.002"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02033-2015"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.08.018"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00272-20"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01950-19"},{"key":"e_1_3_3_26_2","unstructured":"Oxford Immunotec. 2021. T-SPOT.TB package insert. http:\/\/www.oxfordimmunotec.com\/international\/wp-content\/uploads\/sites\/3\/Final-File-PI-TB-US-V6.pdf. Retrieved 4 March 2021."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw694"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/142.suppl1.157"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/595732"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu088"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01547-13"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00482-10"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01048-19"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181a16394"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/364137"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.18-0674"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037851"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00814-14"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2011.02.001"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2009.179.1_MeetingAbstracts.A1014"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu119"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201704-0817OC"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/291294"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187313"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/Spectrum.00096-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/Spectrum.00096-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T08:37:25Z","timestamp":1646728645000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/Spectrum.00096-21"}},"subtitle":[],"editor":[{"given":"Miguel Angel","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,9,3]]}},"alternative-id":["10.1128\/Spectrum.00096-21"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00096-21","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"2021-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00096-21"}}